X-linked hyper-IgM syndrome with eosinophilia in a male child: A case report.

X-linked hyper-IgM syndrome with eosinophilia in a male child: A case report.
复制标题

男孩 X 连锁高 IgM 综合征伴嗜酸性粒细胞增多:病例报告

DOI:
10.3892/etm.2015.2261
复制
发表时间:
2015-04
影响因子:
2.7
通讯作者:
Chen Z
Chen Z
中科院分区:
医学4区
文献类型:
--
作者:
Guo LI;Chen BO;Xu B;Lu M;Ning B;Chen Z

文献摘要

参考文献

被引文献

相似文献

高IgM综合征(hyper-IgM syndrome,HIGMs)是一组原发性免疫缺陷疾病,其特征是血清IgM水平正常或升高,而血清IgG、伊加和IgE水平低或缺乏。在这里,我们报告一例X-连锁的高血糖症与一个新的CD 40 L基因突变的嗜酸性粒细胞增多症。患者从4个月大开始出现复发性肺炎和急性呼吸窘迫综合征(ARDS)。免疫学评价显示血清IgM水平正常,血清IgG和伊加水平显著降低。对CD 40 L基因的遗传学分析显示,在外显子5的核苷酸位置410(c.410-2A>G)处存在剪接突变,这在以前的文献中从未报道过。在每3至4周定期静脉注射免疫球蛋白(IVIG)替代治疗和随访期间使用甲氧苄啶-磺胺甲恶唑预防感染后,患者的免疫球蛋白水平恢复正常,无肺部感染。在口服小剂量类固醇药物治疗5个月后,嗜酸性粒细胞计数也恢复正常。综上所述,CD 40 L基因突变的X连锁高IgM综合征伴嗜酸性粒细胞增多症可通过IVIG替代疗法和小剂量类固醇药物成功治疗。
The hyper-IgM syndromes (HIGMs) are a group of primary immune deficiency diseases characterized by a normal or elevated serum level of IgM and low or absent serum levels of IgG, IgA and IgE. Here, we report a case of X-linked HIGM with a new CD40L gene mutation presenting with eosinophilia. The patient experienced recurrent pneumonia and acute respiratory distress syndrome (ARDS) from 4 months of age. Immunological evaluation revealed a normal level of serum IgM, with significantly low levels of serum IgG and IgA. Genetic analysis of the CD40L gene revealed a splice mutation in exon 5 at the nucleotide position 410 (c.410-2A>G), which has never been reported previously in the literature. Following treatment with regular intravenous immunoglobulin (IVIG) replacement therapy every 3 to 4 weeks and infection prophylaxis with trimethoprim-sulfamethoxazole during follow-up, the patient’s immunoglobulin level returned to normal with no pulmonary infection. The eosinophil count also returned to normal after a small dose of steroid agent treatment was administered orally for 5 months. In summary, X-linked hyper-IgM syndrome with CD40L gene mutation presenting with eosinophilia may be successfully treated using IVIG replacement therapy and a small dose of steroid agent.
DOI: 10.3389/fimmu.2014.00162
发表时间: 2014
影响因子: 7.3
作者:
Al-Herz W;Bousfiha A;Casanova JL;Chatila T;Conley ME;Cunningham-Rundles C;Etzioni A;Franco JL;Gaspar HB;Holland SM;Klein C;Nonoyama S;Ochs HD;Oksenhendler E;Picard C;Puck JM;Sullivan K;Tang ML
通讯作者: Tang ML
亚形核因子-kappaB 必需调节剂突变数据库和重建系统可识别表型和免疫多样性。
DOI: 10.1016/j.jaci.2008.08.018
发表时间: 2008-12
影响因子: 14.2
作者:
Hanson, Eric P.;Monaco-Shawver, Linda;Solt, Laura A.;Madge, Lisa A.;Banerjee, Pinaki P.;May, Michael J.;Orange, Jordan S.
通讯作者: Orange, Jordan S.
DOI: 10.1111/j.1365-2141.2010.08077.x
发表时间: 2010-04
影响因子: 6.5
作者:
Davies EG;Thrasher AJ
通讯作者: Thrasher AJ
DOI: 10.1007/s10875-013-9980-4
发表时间: 2014-02-01
影响因子: 9.1
作者:
Cabral-Marques, Otavio;Klaver, Stefanie;Condino-Neto, Antonio
通讯作者: Condino-Neto, Antonio
DOI: 10.1097/01.md.0000100046.06009.b0
发表时间: 2003-11-01
期刊: MEDICINE
影响因子: 1.6
作者:
Winkelstein, JA;Marino, MC;Conley, ME
通讯作者: Conley, ME